Drugs in early clinical development for Systemic Lupus Erythematosus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drugs in early clinical development for Systemic Lupus Erythematosus

Published:2016-04-07 Issue:5 Volume:25 Page:573-583
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Postal Mariana,Sinicato Nailú Angélica,Appenzeller Simone,Niewold Timothy B.

Funder

National Institutes of Health

Conselho Nacional Pesquisa Desenvolvimento-Brasil CNPq

Fundação Apoio À Pesquisa Estado São Paulo-Brasil

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/13543784.2016.1162291

Reference69 articles.

1. Biologics in the treatment of systemic lupus erythematosus

2. A 2014 update on the management of patients with systemic lupus erythematosus

3. Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies

4. Targeted therapies in systemic lupus erythematosus: successes, failures and future

5. A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application potential of iMSCs and iMSC-EVs in diseases;Frontiers in Bioengineering and Biotechnology;2024-07-29

2. From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies;Autoimmunity Reviews;2023-10

3. A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Fas mice with proliferative lupus nephritis predicts low effect size;Kidney International;2021-06

4. Type I interferon in the pathogenesis of systemic lupus erythematosus;Current Opinion in Immunology;2020-12

5. Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review;Seminars in Arthritis and Rheumatism;2020-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3